Updating results

Get involved

It's our policy to ensure expenses incurred on NICE business are reimbursed promptly and appropriately. To help with this we use an online expense...

Published August 2019 Last updated August 2019

Public Health Advisory Committees

Public Health Advisory Committees (PHACs) are the standing committees responsible for the development of NICE public health guidance. Each PHAC...

Published August 2019 Last updated August 2019

Dapagliflozin with insulin for treating type 1 diabetes (TA597)

Evidence-based recommendations on dapagliflozin (Forxiga) with insulin for type 1 diabetes not controlled by insulin therapy alone in adults with a BMI of at

Technology appraisal guidance Published August 2019

Health of people in the criminal justice system

Everything NICE has said on managing the physical and mental health of people in prison, and the mental health of people in the criminal justice system

NICE Pathway Published November 2016 Last updated August 2019

Type 2 diabetes in adults

Everything NICE has said on managing type 2 diabetes in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Indicator Advisory Committee (IAC)

We work with an independent Indicator Advisory Committee (IAC) to develop indicators suitable for potential inclusion in the Quality and Outcomes...

Published August 2019 Last updated August 2019

Hypertension in adults: diagnosis and management (NG136)

This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.

NICE guideline Published August 2019

Type 2 diabetes in adults: management (NG28)

This guideline covers the care and management of type 2 diabetes in adults (aged 18 and over). It focuses on patient education, dietary advice, managing cardiovascular risk, managing blood glucose levels, and identifying and managing long-term complications.

NICE guideline Published December 2015 Last updated August 2019

Olaparib for maintenance treatment of BRCA mutation-positive advanced ovarian, fallopian tube or peritoneal cancer after response to first-line platinum-based chemotherapy (TA598)

Evidence-based recommendations on olaparib (Lynparza) for treating BRCA mutation-positive, advanced ovarian, fallopian tube or primary peritoneal cancer

Technology appraisal guidance Published August 2019

Methodology day presentations: 13 June 2019

Methodology day presentations - 13 June 2019 Principles underlying the development of NICE guidance - Steven Barnes. An introduction to how health

Published August 2019 Last updated August 2019

Community pharmacies: promoting health and wellbeing

Everything NICE has said on how community pharmacies can promote health and wellbeing in an interactive flowchart

NICE Pathway Published August 2018 Last updated August 2019

Hypertension

Everything NICE has said on managing hypertension in adults in an interactive flowchart

NICE Pathway Published August 2011 Last updated August 2019

Apps for smartphones and tablets

NICE apps for android and apple devices. Includes BNF, BNFC and NICE guidance.

Published August 2019 Last updated August 2019

Type 1 diabetes in adults

Everything NICE has said on diagnosing and managing type 1 diabetes in adults in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Ovarian cancer

Everything NICE has said on recognising and managing ovarian cancer in an interactive flowchart

NICE Pathway Published February 2012 Last updated August 2019

Our projects and partners

NICE research projects and partners.

Published August 2019 Last updated August 2019

Patient access schemes liaison unit

Patient access schemes and the NICE Patient Access Liaison Unit When assessing new drugs and treatments, NICE looks at the cost of the treatment and...

Published August 2019 Last updated August 2019

Senior management team interests register

Outside interests of the NICE senior management team

Published August 2019 Last updated August 2019

NICE to work with company on addressing issues in appraisals of cannabidiol for treating difficult to control epilepsies

NICE has today (23 August 2019) announced its intention to work with GW Pharma to address the issues highlighted by its independent appraisal committee in its evaluation of cannabidiol for treating 2 types of severe treatment-resistant epilepsy.

News Published August 2019 Last updated August 2019

Masterclasses for voluntary and community sector organisations

Workshops to help voluntary and community sector organisations learn more about NICE's activities

Published August 2019 Last updated August 2019

RWE Navigator feedback

Please complete all the required fields before submitting the form.RWE Navigator feedback form 1. Please tell us about yourself. Which

Published August 2019 Last updated August 2019

Enabling Intermediate Care

Shared learning Published July 2019

About

The National Institute for Health and Care Excellence (NICE) provides national guidance and advice to improve health and social care. Who we are

Published August 2019 Last updated August 2019

Sir Andrew Dillon to stand down as NICE chief executive

Chief executive has been at the helm of the institute since it was founded in April 1999

News Published August 2019 Last updated August 2019

Behaviour change

Everything NICE has said on changing people's health-related behaviours, including interventions aimed at over 16s, in an interactive flowchart

NICE Pathway Published January 2014 Last updated August 2019

Scientific advice

Advice from NICE to help you generate evidence to inform future NICE evaluations and to enable market access

Published August 2019 Last updated August 2019

European Early Dialogues

Designed for developers of medicinal products and other similarly regulated technologies. Receive advice from NICE, the European Medicines Agency...

Published August 2019 Last updated August 2019

Express scientific advice

Our express service is designed for companies who need to receive scientific advice within more challenging timeframes. Within 12 weeks, you'll...

Published August 2019 Last updated August 2019

Medtech advice

Scientific advice medtech advice

Published August 2019 Last updated August 2019

NICE-MHRA scientific advice

Designed for developers of medicinal products and other similarly regulated technologies. Allows you to seek joint regulatory advice from the...

Published August 2019 Last updated August 2019

Preliminary Independent Model Advice (PRIMA)

Advice on improving the quality of economic models

Published August 2019 Last updated August 2019

Seminars

Training seminars and workshops for those in the pharmaceutical, medical technology or cell and gene therapy sectors

Published August 2019 Last updated August 2019

Site visits

Find out more about why engaging with us early is important. We will: introduce NICE present NICE Scientific Advice explain how to complete the

Published August 2019 Last updated August 2019

Speaking engagements

Book one of our scientific advice team to speak at your event

Published August 2019 Last updated August 2019

Standard scientific advice

Designed for those seeking advice in either pharmaceutical or medical technologies. Provides the highest level of detail of all our advice processes.

Published August 2019 Last updated August 2019

GP reference panel survey feedback

Feedback from the GP reference panel survey

Published August 2019 Last updated August 2019

Promoting independence through intermediate care

Promoting independence through intermediate care - a quick guide for staff delivering intermediate care services.

Published August 2019 Last updated August 2019

Pharmaceutical products

Scientific advice for developers of pharmaceuticals

Published August 2019 Last updated August 2019

Library and knowledge services staff

NICE Evidence Services issues View the latest issues affecting NICE Evidence Services (Healthcare Databases Advanced Search(HDAS), Evidence Search

Published August 2019 Last updated August 2019

Risankizumab for treating moderate to severe plaque psoriasis (TA596)

Evidence-based recommendations on risankizumab (Skyrizi) for treating moderate to severe plaque psoriasis in adults

Technology appraisal guidance Published August 2019

Osteoporosis

Everything NICE has said on assessing the risk of, preventing and treating osteoporotic fragility fractures in adults in an interactive flowchart

NICE Pathway Published August 2012 Last updated August 2019

Psoriasis

Everything NICE has said on psoriasis in an interactive flowchart

NICE Pathway Published October 2011 Last updated August 2019

Obesity

Everything NICE has said on preventing, identifying, assessing and managing obesity in an interactive flowchart

NICE Pathway Published October 2013 Last updated August 2019

Alcohol-use disorders

Everything NICE has said on preventing, diagnosing and managing alcohol-related disorders in an interactive flowchart

NICE Pathway Published May 2011 Last updated August 2019

Coexisting severe mental illness and substance misuse (QS188)

This quality standard covers the assessment, management and care provided for people aged 14 and over who have coexisting severe mental illness and substance misuse. It describes high-quality care in priority areas for improvement.

Quality standard Published August 2019

Technology appraisal processes

We use 3 processes for assessing technologies: the single technology appraisal, the multiple technology appraisal and the fast track appraisal.

Published August 2019 Last updated August 2019

Coexisting severe mental illness and substance misuse: community health and social care services

Everything NICE has said on severe mental illness and substance misuse (dual diagnosis) for people over 14 in community services in an interactive flowchart

NICE Pathway Published November 2016 Last updated August 2019

Coexisting severe mental illness and substance misuse: assessment and management in healthcare settings

Everything NICE has said about assessing and managing coexisting severe mental illness and substance misuse in healthcare settings in an interactive flowchart

NICE Pathway Published September 2012 Last updated August 2019

What is the clinical and cost effectiveness of intermittent auscultation compared with continuous cardiotocography for women in labour who have had a previous caesarean section?

Recommendation ID NG121/5 Question What is the clinical and cost effectiveness of intermittent auscultation compared with continuous cardiotocography

Research recommendation Published August 2019